Mult Scler Relat Disord
August 2025
Aim: To compare retinal ganglion cell function between optic neuritis (ON) cases positive for anti-aquaporin-4 antibody (AQP4+) and myelin oligodendrocyte glycoprotein (MOG+).
Methods: Patients tested positive for AQP4 or MOG and history of ON at least six months prior to enrollment were included. An ophthalmological examination, visual acuity test (BCVA), visual field test (mean deviation, MD) and spectral-domain optical coherence tomography (OCT) were performed.
Am J Ophthalmol Case Rep
September 2025
Purpose: To report a case of combined Descemet membrane endothelial keratoplasty (DMEK) and secondary sulcus hydrophobic intraocular lens (IOL) implantation for hyperopic correction in a pseudophakic eye with Fuchs' endothelial corneal dystrophy.
Observation: A 74-year-old woman with Fuchs' dystrophy and a history of phacoemulsification with a hydrophilic IOL in her left eye (refraction: +5.25 D/-1.
Purpose: To evaluate the predictability of postoperative refraction for a capsulotomy-fixated intraocular lens (IOL) after femtosecond laser-assisted cataract surgery (FLACS).
Methods: Patients with age-related cataracts and no other eye disease who were implanted with the FEMTIS FB-313 IOL (Teleon Surgical BV) during FLACS were included. Using an IOLMaster 700 (Carl Zeiss Meditec), subjective refractive and biometric data were collected preoperatively and at a minimum of 3 months postoperatively.
Purpose: To describe extensive macular atrophy with pseudodrusen (EMAP) using multimodal imaging and analyze factors associated with visual loss.
Methods: This observational case seriesretrospectively reviewed the clinical and multimodal imaging (color fundus photography [CFP], fluorescein angiography, fundus autofluorescence (FAF), and optical coherence tomography [OCT]) of patients between January and December 2023. The EMAP diagnosis was based on early-onset macular atrophy, pseudodrusen, and bilateral disease.
Graefes Arch Clin Exp Ophthalmol
May 2025
Purpose: To describe early cone changes detected by adaptive optics (AO) in patients on chronic hydroxychloroquine (HC) treatment with no abnormalities on standard functional or structural retinal tests.
Methods: Case-control study including 36 eyes of 36 female patients. Cases included 18 women on HC for autoimmune disease whose cumulative dose exceeded 1600 g and who demonstrated no evidence of retinal toxicity on visual field (VF), spectral domain optical coherence tomography (SD-OCT), or multifocal electroretinography (mfERG).
Purpose: To analyze the clinical outcome of organ-cultured endothelium-outward preloaded DMEK (pDMEK) using the RAPID cartridge.
Methods: This prospective study included 80 eyes of 80 patients who received a pDMEK. Best-corrected visual acuity (BCVA), endothelial cell count (ECC), and central corneal thickness were measured preoperatively and 4 to 6 weeks, 3 months, 6 months, and 1 year postoperatively.
Arq Bras Oftalmol
November 2024
Indian J Ophthalmol
November 2024
Purpose: To investigate predictors for myopic shift after pediatric cataract surgery after at least 3 years follow-up.
Study Design: Cross-sectional and retrospective study.
Methods: This study included patients treated for congenital or infantile cataract operated up to 5 years of age between 2010 and 2017.
J Cataract Refract Surg
September 2024
Purpose: To investigate long-term astigmatism after combined nonpenetrating glaucoma surgery (NPGS) and implantation of the first miniaturized suprachoroidal intraocular pressure (IOP) sensor EYEMATE-SC.
Setting: The study was conducted in 5 medical centers in 2 different countries.
Design: Retrospective multicenter clinical study.
Purpose: To evaluate the saccadic movements of patients with visual field loss due to primary open-angle glaucoma.
Methods: Thirteen patients with good visual acuity (0.2 logMAR or better) (seven patients with primary open-angle glaucoma 65 ± 13 years) and six controls (51 ± 6 years) yielded a comprehensive ophthalmological examination, including Humphrey Visual Field tests (SITA-Standard 24-2), and performed a monocular, exploratory digital visual search task that quantifies the duration for finding the number "4" on a random array of digits distributed on the screen.
Background: Anti-myelin oligodendrocyte glycoprotein (anti-MOG) antibody-associated disease (MOGAD) is an immune-mediated neurological disorder with a broad spectrum of clinical presentation that is often difficult to distinguish from other demyelinating diseases, such as multiple sclerosis and neuromyelitis optica spectrum disorder.
Objective: To describe the clinical and paraclinical characteristics of MOGAD in a Brazilian tertiary center.
Methods: We retrospectively reviewed the records of adult and pediatric patients who tested positive for anti-MOG antibodies and presented with clinical and radiological diseases compatible with MOGAD.
Purpose: To compare visual performance and photic visual disturbances of patients implanted with 2 different extended depth-of-focus (EDOF) intraocular lenses (IOLs) using mini-monovision.
Setting: Ambulatory surgical center at the University of São Paulo in Ribeirão Preto, Brazil.
Design: Prospective, examiner-masked, randomized clinical trial.
Int J Retina Vitreous
September 2023
Purpose: Approximately half of the children operated on for cataracts develop strabismus. We determined what factors predict its development.
Methods: In a retrospective, cross-sectional study, children who underwent cataract surgery before age 5 between 2010 and 2017 in a tertiary center in Brazil were identified from medical records.
Background: Pseudophakic cystoid macular edema (PCME) is the most common cause of visual acuity deterioration after uncomplicated cataract surgery. There is no consensus regarding how to manage recurrent or refractory cases.
Report: A 54-year-old woman complained of decreased vision and central metamorphopsia in the right eye (OD) 3 months after uneventful cataract surgery.
Int J Retina Vitreous
April 2023
Background: Given the persistently large public health impact of neovascular age-related macular degeneration (nARMD) despite many years of anti-VEGF therapy as the first-line treatment and the demonstrated ability of b-blockers to reduce neovascularization, a synergistic effect between an anti-VEGF agent and an intravitreal beta-blocker is important to investigate in the quest for therapeutic alternatives that maximize efficacy and/or reduce costs. The main purpose of this study is to investigate the safety of a 0.1 ml intravitreal injection of a combination of bevacizumab (1.
View Article and Find Full Text PDFPurpose: To investigate ocular safety of intravitreal metoprolol in eyes with central serous chorioretinopathy.
Methods: Five eyes of five patients diagnosed with chronic central serous chorioretinopathy (cCSC) previously treated unsuccessfully with oral spironolactone, micropulse laser and intravitreal anti-vascular endothelial growth factor agents were enrolled and received off-label intravitreal metoprolol (50 µg/0.05 ml).
Achromatopsia (ACHM) is a congenital cone photoreceptor disorder characterized by impaired color discrimination, low visual acuity, photosensitivity, and nystagmus. To date, six genes have been associated with ACHM (CNGA3, CNGB3, GNAT2, PDE6C, PDE6H, and ATF6), the majority of these being implicated in the cone phototransduction cascade. CNGA3 encodes the CNGA3 subunit of the cyclic nucleotide-gated ion channel in cone photoreceptors and is one of the major disease-associated genes for ACHM.
View Article and Find Full Text PDFArq Bras Oftalmol
December 2022
Myelin oligodendrocyte glycoprotein-immunoglobulin G (IgG)-associated optic neuritis has been established as a new entity of immune-mediated optic neuropathy. Patients usually present with recurrent optic neuritis, often bilaterally with initially severe vision loss and optic disc edema. However, in contrast to aquaporin 4-IgG-seropositive neuromyelitis optica spectrum disorder, visual recovery tends to be more favorable, with good response to steroid treatment.
View Article and Find Full Text PDFArq Bras Oftalmol
May 2023
Purpose: To report retinal function findings on the choroidal nevus.
Methods: Prospective descriptive case series of 7 patients ( = 7 eyes) presenting a melanocytic choroidal lesion consistent with choroidal nevus and no other ocular disease. Baseline evaluation included measurement of best-corrected visual acuity (BCVA), color and near-infrared fundus pictures, and spectral-domain OCT (Heidelberg Engineering).
Purpose: To compare ETDRS panretinal laser photocoagulation (PRP) combined with intravitreal injection of ranibizumab (IVR) and photocoagulation targeted to ischemic retina (PIR) combined with IVR in patients with proliferative diabetic retinopathy (PDR).
Methods: PDR patients were randomly assigned to treatment with either PRP + IVR or PIR + IVR. ETRDS Best-corrected visual acuity (BCVA) and central subfield thickness (CSFT) measured on optic-coherence tomography images (OCT-Heidelberg Spectralis) were recorded at baseline and every 4 weeks for one year.
Graefes Arch Clin Exp Ophthalmol
September 2021
Background: Choroidal hemangioma is a visual threatening condition for which treatments is neither uniform nor widely available. New management options are necessary. The purpose of this study is to assess the safety and early outcome of intravitreal metoprolol tartrate in five patients with CCH.
View Article and Find Full Text PDFPurpose: To evaluate the influence of pupil dynamics on the defocus profile and area-of-focus of eyes implanted with a diffractive multifocal intraocular lens (IOL).
Methods: This prospective randomized trial was conducted at the Department of Ophthalmology, School of Medicine of Ribeirão Preto, University of São Paulo, Brazil. Thirty-eight patients were randomly assigned to receive the multifocal SN6AD1 (n=20) or the aspheric monofocal SN60WF (aIOL) (n=18) IOLs bilaterally.